Alrex
loteprednol etabonate
- Strength
- 2 mg/mL
- Form
- Suspension/ Drops
- Class
- Corticosteroid
Bausch & Lomb Incorporated
Not stocked by us — reference only
Loteprednol Etabonate
Listed by Alcon Laboratories, Inc.
| Dosage form | Suspension |
|---|---|
| Route | Ophthalmic |
| Drug class | Corticosteroid |
| Approval route | NDA — original brand approval |
| NDC code | 0065-9307 |
| FDA application | NDA210565 |
| RxNorm concept | 2055281 |
| Package sizes listed | 2 |
| Marketed since | April 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
loteprednol etabonate
Bausch & Lomb Incorporated
Not stocked by us — reference only
loteprednol etabonate
ALCON LABORATORIES, INC.
Not stocked by us — reference only
loteprednol etabonate
ALCON LABORATORIES, INC.
Not stocked by us — reference only
loteprednol etabonate
Bausch & Lomb Incorporated
Not stocked by us — reference only
loteprednol etabonate
Bausch & Lomb Incorporated
Not stocked by us — reference only
loteprednol etabonate
Bausch & Lomb Incorporated
Not stocked by us — reference only
loteprednol etabonate
Bausch & Lomb Incorporated
Not stocked by us — reference only
Bausch & Lomb Americas Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.